Sign inGet started

ValueAct Co-Invest Master Fund, L.P.

Insider CIK 1579734 · MSFT Director · VRX Director · VRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BHC Bausch Health Companies In P Buy2020-06-052020-06-09948,353$19.24 $18.25M17,931,594SEC↗
BHC Bausch Health Companies In S Sale2020-06-052020-06-09948,353$19.24 $18.25M0SEC↗
BHC Bausch Health Companies In A Award2020-05-012020-05-0111,037— $021,046SEC↗
BHC Bausch Health Companies In F Tax w/h2020-04-292020-05-01624$18.11 $11.3K10,009SEC↗
BHC Bausch Health Companies In J Other2019-06-132019-06-14111,440— $0948,353SEC↗
BHC Bausch Health Companies In A Award2019-05-032019-05-0310,633$23.51 $250.0K20,518SEC↗
BHC Bausch Health Companies In F Tax w/h2019-05-012019-05-033,996$23.63 $94.4K9,885SEC↗
VRX Valeant Pharmaceuticals In A Award2018-05-032018-05-0414,285— $035,897SEC↗
VRX Valeant Pharmaceuticals In A Award2018-05-032018-05-0813,881— $035,493SEC↗
VRX Valeant Pharmaceuticals In F Tax w/h2018-05-012018-05-033,794$18.07 $68.6K21,612SEC↗
MSFT MICROSOFT CORP A Award2017-11-282017-11-30589— $0589SEC↗
MSFT MICROSOFT CORP A Award2017-08-302017-08-31675— $0675SEC↗
MSFT MICROSOFT CORP S Sale2017-08-082017-08-08278,000$72.50 $20.16M8,130,850SEC↗
MSFT MICROSOFT CORP S Sale2017-08-082017-08-0830,169$72.50 $2.19M881,949SEC↗
MSFT MICROSOFT CORP S Sale2017-08-072017-08-082,879,500$72.50 $208.76M8,408,850SEC↗
MSFT MICROSOFT CORP S Sale2017-08-072017-08-08312,331$72.50 $22.64M912,118SEC↗
MSFT MICROSOFT CORP S Sale2017-08-042017-08-08342,600$72.61 $24.88M1,224,449SEC↗
MSFT MICROSOFT CORP S Sale2017-08-042017-08-083,157,400$72.61 $229.26M11,288,350SEC↗
MSFT MICROSOFT CORP A Award2017-05-302017-05-31710— $0710SEC↗
VRX Valeant Pharmaceuticals In A Award2017-05-052017-05-0525,406— $038,209SEC↗
MSFT MICROSOFT CORP S Sale2017-05-042017-05-05391,500$68.82 $26.94M1,567,049SEC↗
MSFT MICROSOFT CORP S Sale2017-05-042017-05-053,608,500$68.82 $248.34M14,445,040SEC↗
MSFT MICROSOFT CORP S Sale2017-05-032017-05-05293,600$68.89 $20.23M1,958,549SEC↗
MSFT MICROSOFT CORP S Sale2017-05-032017-05-052,706,400$68.89 $186.44M18,053,540SEC↗
VRX Valeant Pharmaceuticals In F Tax w/h2017-05-032017-05-053,923$9.66 $37.9K12,803SEC↗
VRX Valeant Pharmaceuticals In P Buy2017-03-142017-03-162,500,000$10.81 $27.02M16,937,431SEC↗
VRX Valeant Pharmaceuticals In P Buy2017-03-142017-03-16500,000$10.88 $5.44M14,437,431SEC↗
MSFT MICROSOFT CORP S Sale2017-02-232017-02-231,172,800$64.46 $75.60M20,758,348SEC↗
MSFT MICROSOFT CORP S Sale2017-02-232017-02-23127,200$64.46 $8.20M2,252,149SEC↗
MSFT MICROSOFT CORP S Sale2017-02-222017-02-231,443,400$64.23 $92.71M21,931,148SEC↗
MSFT MICROSOFT CORP S Sale2017-02-222017-02-23156,600$64.23 $10.06M2,379,349SEC↗
MSFT MICROSOFT CORP S Sale2017-02-212017-02-23167,900$64.52 $10.83M2,535,949SEC↗
MSFT MICROSOFT CORP S Sale2017-02-212017-02-231,548,100$64.52 $99.88M23,374,548SEC↗
MSFT MICROSOFT CORP S Sale2017-02-032017-02-031,804,300$63.33 $114.27M24,922,648SEC↗
MSFT MICROSOFT CORP S Sale2017-02-032017-02-03195,700$63.33 $12.39M2,703,849SEC↗
MSFT MICROSOFT CORP S Sale2017-02-022017-02-035,412,800$63.12 $341.66M26,726,948SEC↗
MSFT MICROSOFT CORP S Sale2017-02-022017-02-03587,200$63.12 $37.06M2,899,549SEC↗
MSFT MICROSOFT CORP S Sale2017-02-012017-02-032,706,400$63.72 $172.45M32,139,748SEC↗
MSFT MICROSOFT CORP S Sale2017-02-012017-02-03293,600$63.72 $18.71M3,486,749SEC↗
MSFT MICROSOFT CORP A Award2017-01-312017-02-01773— $01,592SEC↗
MSFT MICROSOFT CORP A Award2016-11-292016-12-01819— $0819SEC↗
MSFT MICROSOFT CORP A Award2016-09-022016-09-06867— $01,819SEC↗
MSFT MICROSOFT CORP S Sale2016-07-282016-07-299,922,000$55.95 $555.14M34,844,329SEC↗
MSFT MICROSOFT CORP S Sale2016-07-282016-07-291,078,000$55.95 $60.31M3,780,349SEC↗
MSFT MICROSOFT CORP S Sale2016-07-272016-07-296,314,000$56.38 $355.98M44,766,329SEC↗
MSFT MICROSOFT CORP S Sale2016-07-272016-07-29686,000$56.38 $38.68M4,858,349SEC↗
VRX Valeant Pharmaceuticals In F Tax w/h2016-07-012016-07-0634$23.78 $80917,840SEC↗
VRX Valeant Pharmaceuticals In A Award2016-06-172016-06-2116,726— $017,874SEC↗
MSFT MICROSOFT CORP A Award2016-06-022016-06-03952— $0952SEC↗
MSFT MICROSOFT CORP A Award2016-01-292016-02-01908— $0908SEC↗
MSFT MICROSOFT CORP A Award2015-12-012015-12-03679— $0679SEC↗
MSFT MICROSOFT CORP S Sale2015-11-112015-11-122,390,520$53.74 $128.47M51,078,742SEC↗
MSFT MICROSOFT CORP S Sale2015-11-112015-11-12259,480$53.74 $13.94M5,544,349SEC↗
MSFT MICROSOFT CORP S Sale2015-11-102015-11-1214,433,328$53.49 $772.04M53,469,262SEC↗
MSFT MICROSOFT CORP S Sale2015-11-102015-11-121,566,672$53.49 $83.80M5,803,829SEC↗
VRX Valeant Pharmaceuticals In A Award2015-10-252016-05-101,883— $01,883SEC↗
VRX Valeant Pharmaceuticals In A Award2015-10-232016-05-091,883— $01,883SEC↗
MSFT MICROSOFT CORP A Award2015-09-032015-09-04862— $0862SEC↗
VRX Valeant Pharmaceuticals In A Award2015-08-192016-05-091,148— $01,148SEC↗
VRX Valeant Pharmaceuticals In G Gift2015-06-112015-06-1246,595— $00SEC↗
VRX Valeant Pharmaceuticals In S Sale2015-06-102015-06-12417,919$230.60 $96.37M17,613,017SEC↗
VRX Valeant Pharmaceuticals In S Sale2015-06-102015-06-12261,790$219.00 $57.33M1,059,793SEC↗
VRX Valeant Pharmaceuticals In J Other2015-06-102015-06-12189,616— $013,934,468SEC↗
VRX Valeant Pharmaceuticals In J Other2015-06-102015-06-1246,595— $046,595SEC↗
VRX Valeant Pharmaceuticals In S Sale2015-06-102015-06-123,488,933$219.00 $764.08M14,124,084SEC↗
VRX Valeant Pharmaceuticals In S Sale2015-06-102015-06-1231,358$230.60 $7.23M1,321,583SEC↗
MSFT MICROSOFT CORP A Award2015-06-032015-06-04800— $0800SEC↗
VRX VALEANT PHARMACEUTICALS IN F Tax w/h2015-05-262015-05-27124$224.63 $27.9K3,117SEC↗
VRX VALEANT PHARMACEUTICALS IN A Award2015-05-222015-05-271,607— $03,241SEC↗
MSFT MICROSOFT CORP P Buy2015-02-042015-02-04106,258$41.42 $4.40M67,500,000SEC↗
MSFT MICROSOFT CORP P Buy2015-02-042015-02-04200,000$41.47 $8.29M67,700,000SEC↗
MSFT MICROSOFT CORP P Buy2015-02-042015-02-04200,000$41.49 $8.30M67,900,000SEC↗
MSFT MICROSOFT CORP P Buy2015-02-022015-02-04151,000$40.79 $6.16M67,018,742SEC↗
MSFT MICROSOFT CORP P Buy2015-02-022015-02-04100,000$40.79 $4.08M67,118,742SEC↗
MSFT MICROSOFT CORP P Buy2015-02-022015-02-04200,000$40.88 $8.18M67,318,742SEC↗
MSFT MICROSOFT CORP P Buy2015-02-022015-02-0475,000$40.93 $3.07M67,393,742SEC↗
MSFT MICROSOFT CORP A Award2015-01-302015-02-02928— $0928SEC↗
VRX Valeant Pharmaceuticals In P Buy2014-12-102014-12-1150,000$139.29 $6.96M18,030,936SEC↗
VRX Valeant Pharmaceuticals In P Buy2014-12-092014-12-11200,000$140.25 $28.05M17,980,936SEC↗
MSFT MICROSOFT CORP A Award2014-12-022014-12-03774— $0774SEC↗
VRX Valeant Pharmaceuticals In P Buy2014-11-242014-11-26210,000$142.25 $29.87M17,780,936SEC↗
VRX Valeant Pharmaceuticals In A Award2014-11-212014-11-251,634— $01,634SEC↗
MSFT MICROSOFT CORP A Award2014-08-192014-08-20827— $0827SEC↗
MSFT MICROSOFT CORP J Other2014-06-052014-06-09611— $00SEC↗
MSFT MICROSOFT CORP A Award2014-05-192014-05-20611— $0611SEC↗
MSFT MICROSOFT CORP P Buy2014-05-092014-05-12500,000$39.59 $19.80M7,370,501SEC↗
MSFT MICROSOFT CORP P Buy2014-05-092014-05-12463,000$39.54 $18.31M5,470,501SEC↗
MSFT MICROSOFT CORP P Buy2014-05-092014-05-12600,000$39.58 $23.75M6,870,501SEC↗
MSFT MICROSOFT CORP P Buy2014-05-092014-05-12800,000$39.56 $31.65M6,270,501SEC↗
MSFT MICROSOFT CORP P Buy2014-05-082014-05-12287,501$39.50 $11.36M5,007,501SEC↗
MSFT MICROSOFT CORP P Buy2014-05-082014-05-12300,000$39.49 $11.85M4,720,000SEC↗
VRX Valeant Pharmaceuticals In P Buy2013-06-192013-06-211,352,941$85.00 $115.00M1,352,941SEC↗